Literature DB >> 8647432

Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

K Alexandropoulos1, D Baltimore.   

Abstract

To understand how protein-protein interactions mediated by the Src-SH3 domain affect c-Src signaling, we screened for proteins that interact with the Src-SH3. We found a novel protein, Sin (Src interacting or signal integrating protein), that binds to Src-SH3 with high affinity, contains numerous tyrosine residues in configurations suggestive of SH2-binding sites, and is related to the v-Src substrate p130Cas. In cotransfection assays, a small fragment of Sin retaining the Src-SH3-binding site and one tyrosine-containing motif induced c-Src activation as measured by a transcriptional reporter. Phosphorylation of the peptide on tyrosine by c-Src, as a consequence of Src-SH3 binding, was necessary for its stable interaction with c-Src in vivo and for transcriptional activation. Phosphorylation of multiple tyrosine-containing motifs found on Sin correlated with c-Crk and cellular phosphoprotein binding to Sin as well as increased c-Src activity. These data suggest that (1) SH2 and SH3 ligand sites on Sin cooperatively activate the signaling potential of c-Src, (2) Sin acts as both an activator and a substrate for c-Src, and (3) phosphorylated Sin may serve as a signaling effector molecule for Src by binding to multiple cellular proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647432     DOI: 10.1101/gad.10.11.1341

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  71 in total

1.  Fyn and Lck tyrosine kinases regulate tyrosine phosphorylation of p105CasL, a member of the p130Cas docking protein family, in T-cell receptor-mediated signalling.

Authors:  H Kanda; T Mimura; K Hamasaki; K Yamamoto; Y Yazaki; H Hirai; Y Nojima
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

2.  Regulation of c-Fes tyrosine kinase and biological activities by N-terminal coiled-coil oligomerization domains.

Authors:  H Cheng; J A Rogers; N A Dunham; T E Smithgall
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.

Authors:  C E Andoniou; N L Lill; C B Thien; M L Lupher; S Ota; D D Bowtell; R M Scaife; W Y Langdon; H Band
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics.

Authors:  G M O'Neill; E A Golemis
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  CMS: an adapter molecule involved in cytoskeletal rearrangements.

Authors:  K H Kirsch; M M Georgescu; S Ishimaru; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.

Authors:  Keith Q Tanis; Darren Veach; Henry S Duewel; William G Bornmann; Anthony J Koleske
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

Review 7.  Determinants of substrate recognition in nonreceptor tyrosine kinases.

Authors:  W Todd Miller
Journal:  Acc Chem Res       Date:  2003-06       Impact factor: 22.384

8.  The adapter molecule Sin regulates T-cell-receptor-mediated signal transduction by modulating signaling substrate availability.

Authors:  Luzhou Xing; Laura T Donlin; Rebecca H Miller; Konstantina Alexandropoulos
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Cooperative activation of Src family kinases by SH3 and SH2 ligands.

Authors:  Shalini S Yadav; W Todd Miller
Journal:  Cancer Lett       Date:  2007-08-24       Impact factor: 8.679

10.  Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src.

Authors:  P J Ruest; N Y Shin; T R Polte; X Zhang; S K Hanks
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.